These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31535597)

  • 21. Temporal indication of marijuana use can be estimated from plasma and urine concentrations of delta9-tetrahydrocannabinol, 11-hydroxy-delta9-tetrahydrocannabinol, and 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid.
    Manno JE; Manno BR; Kemp PM; Alford DD; Abukhalaf IK; McWilliams ME; Hagaman FN; Fitzgerald MJ
    J Anal Toxicol; 2001 Oct; 25(7):538-49. PubMed ID: 11599597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. THCCOOH concentrations in whole blood: are they useful in discriminating occasional from heavy smokers?
    Fabritius M; Favrat B; Chtioui H; Battistella G; Annoni JM; Appenzeller M; Dao K; Fornari E; Lauer E; Mall JF; Maeder P; Mangin P; Staub C; Giroud C
    Drug Test Anal; 2014; 6(1-2):155-63. PubMed ID: 24173827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimization of recombinant β-glucuronidase hydrolysis and quantification of eight urinary cannabinoids and metabolites by liquid chromatography tandem mass spectrometry.
    Sempio C; Scheidweiler KB; Barnes AJ; Huestis MA
    Drug Test Anal; 2018 Mar; 10(3):518-529. PubMed ID: 28815938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma cannabinoid concentrations during dronabinol pharmacotherapy for cannabis dependence.
    Milman G; Bergamaschi MM; Lee D; Mendu DR; Barnes AJ; Vandrey R; Huestis MA
    Ther Drug Monit; 2014 Apr; 36(2):218-24. PubMed ID: 24067260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Automated extraction and LC-MS-MS analysis of 11-nor-9-carboxy-tetrahydrocannabinol isomers and prevalence in authentic urine specimens.
    Karas LK; Patterson C; Fuller ZJ; Karschner EL
    J Anal Toxicol; 2024 May; 48(4):197-203. PubMed ID: 38581658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cannabinoid concentrations in hair from documented cannabis users.
    Huestis MA; Gustafson RA; Moolchan ET; Barnes A; Bourland JA; Sweeney SA; Hayes EF; Carpenter PM; Smith ML
    Forensic Sci Int; 2007 Jul; 169(2-3):129-36. PubMed ID: 16963215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute Pharmacokinetic Profile of Smoked and Vaporized Cannabis in Human Blood and Oral Fluid.
    Spindle TR; Cone EJ; Schlienz NJ; Mitchell JM; Bigelow GE; Flegel R; Hayes E; Vandrey R
    J Anal Toxicol; 2019 May; 43(4):233-258. PubMed ID: 30615181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fitness to drive and cannabis: validation of two blood THCCOOH thresholds to distinguish occasional users from heavy smokers.
    Fabritius M; Augsburger M; Chtioui H; Favrat B; Giroud C
    Forensic Sci Int; 2014 Sep; 242():1-8. PubMed ID: 24999608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of in utero cannabis exposure by umbilical cord analysis.
    Kim J; de Castro A; Lendoiro E; Cruz-Landeira A; López-Rivadulla M; Concheiro M
    Drug Test Anal; 2018 Apr; 10(4):636-643. PubMed ID: 28948698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biological correlates of self-reported new and continued abstinence in cannabis cessation treatment clinical trials.
    Baker NL; Gray KM; Sherman BJ; Morella K; Sahlem GL; Wagner AM; McRae-Clark AL
    Drug Alcohol Depend; 2018 Jun; 187():270-277. PubMed ID: 29698894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An investigation of the stability of free and glucuronidated 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid in authentic urine samples.
    Skopp G; Pötsch L
    J Anal Toxicol; 2004; 28(1):35-40. PubMed ID: 14987422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabinoids and metabolites in expectorated oral fluid after 8 days of controlled around-the-clock oral THC administration.
    Milman G; Barnes AJ; Schwope DM; Schwilke EW; Goodwin RS; Kelly DL; Gorelick DA; Huestis MA
    Anal Bioanal Chem; 2011 Aug; 401(2):599-607. PubMed ID: 21637933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle.
    Niedbala RS; Kardos KW; Fritch DF; Kunsman KP; Blum KA; Newland GA; Waga J; Kurtz L; Bronsgeest M; Cone EJ
    J Anal Toxicol; 2005 Oct; 29(7):607-15. PubMed ID: 16419389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a rapid column-switching LC-MS/MS method for the quantification of THCCOOH and THCCOOH-glucuronide in whole blood for assessing cannabis consumption frequency.
    Hädener M; Weinmann W; Schürch S; König S
    Anal Bioanal Chem; 2016 Mar; 408(7):1953-62. PubMed ID: 26781107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 11-Nor-9-carboxy-∆9-tetrahydrocannabinol quantification in human oral fluid by liquid chromatography-tandem mass spectrometry.
    Scheidweiler KB; Himes SK; Chen X; Liu HF; Huestis MA
    Anal Bioanal Chem; 2013 Jul; 405(18):6019-27. PubMed ID: 23681203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary excretion profiles of 11-nor-9-carboxy-delta9-tetrahydrocannabinol: a delta9-THCCOOH to creatinine ratio study.
    Fraser AD; Worth D
    J Anal Toxicol; 1999 Oct; 23(6):531-4. PubMed ID: 10517562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Free and Glucuronide Urine Cannabinoids after Controlled Smoked, Vaporized and Oral Cannabis Administration in Frequent and Occasional Cannabis Users.
    Huestis MA; Sempio C; Newmeyer MN; Andersson M; Barnes AJ; Abulseoud OA; Blount BC; Schroeder J; Smith ML
    J Anal Toxicol; 2020 Oct; 44(7):651-660. PubMed ID: 32369162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temporal indication of cannabis use by means of THC glucuronide determination.
    Mareck U; Haenelt N; Geyer H; Guddat S; Kamber M; Brenneisen R; Thevis M; Schänzer W
    Drug Test Anal; 2009 Nov; 1(11-12):505-10. PubMed ID: 20355165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of marijuana use by oral fluid and urine analysis following single-dose administration of smoked and oral marijuana.
    Niedbala RS; Kardos KW; Fritch DF; Kardos S; Fries T; Waga J; Robb J; Cone EJ
    J Anal Toxicol; 2001; 25(5):289-303. PubMed ID: 11499881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of nitrite adulteration on the immunoassay and GC-MS analysis of cannabinoids in urine specimens.
    Tsai LS; ElSohly MA; Tsai SF; Murphy TP; Twarowska B; Salamone SJ
    J Anal Toxicol; 2000; 24(8):708-14. PubMed ID: 11110026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.